Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07464119) titled 'A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy' on March 4.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Peking University First Hospital

Condition: Diabetes Mellitus

Intervention: Biological: iPSC-derived islet cell

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 16, 2026

Target Sample Size: 30

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07464119

Disclaimer: Curated by ...